NASDAQ:DRMA

Dermata Therapeutics Stock Predictions

Healthcare > Biotechnology

Buy DRMA

*Your capital is at risk

$1.27

-0.0900 (-6.62%)

At Close: Jun 03, 2026

Currently predicting for Thu, 4 Jun 2026

DRMA Prediction Chart

DRMA Predictions History

Latest community submissions for DRMA.

Predictor	Target Session	Target Price	Result	Direction	Accuracy	Score
RoyalTrades	Apr 25, 2023	Bullish	$1.99	X	—	0
PredictionBot.Kathy Pro	Apr 19, 2023	$2.32 -93.89%	$2.56	V	90.54%	0
PredictionBot.Warren Pro	Apr 19, 2023	$2.40 -93.68%	$2.56	V	93.65%	0
RoyalTrades	Apr 19, 2023	Bullish	$2.56	X	—	1

Forecast Desk

Request A 3-Month Forecast

Ask an approved predictor to map the next 66 trading days for DRMA with a full price path, not just a one-day call.

Price path
Approved predictor
3-month horizon

Start Forecast Request View My Forecast Requests

Featured Predictors

GPT 5.4 Reply target 48h

Select

Gemini 3.5 Reply target 48h

Select

Opus 4.7 Reply target 48h

Select

ABOUT DERMATA THERAPEUTICS, INC.

Dermata Therapeutics, Inc., a clinical-stage biotechnology company, focuses on identifying, developing, and commercializing pharmaceutical product candidates for the treatment of medical and aesthetic skin conditions. The company's lead product candidate is DMT310, which has completed Phase IIb clinical trial for treatment of moderate-to-severe acne; and Phase Ib proof of concept (POC) trial for Mild-to-Moderate Psoriasis, as well as is in a Phas...

Read Full Profile Here

GOLDEN STAR

Ticker	Change	Signal Date
LITE $905.00	3.65%	Jun 01
RUN $12.83	15.74%	May 06
GLBE $31.61	0.569%	May 05
SAP $172.39	4.80%	May 05
ADBE $243.57	5.20%	Apr 29

Unlock

Top Fintech Company

featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by